Natalie Kitamura
Family · Pearl City, HINPI 1346551249
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.2% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in HI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $52.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Jazz Pharmaceuticals Inc.$2K
- Harmony Biosciences LLC$1K
- AbbVie$1K
- Lilly USA, LLC$691
- Revance Therapeutics, Inc.$574
- plus $3K from 21 others
What the payments were for
- Food & beverage$10,54996%
- Education$4134%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 50 | $2,630 |
| Jazz Pharmaceuticals Inc. | 25 | $1,516 |
| Harmony Biosciences LLC | 29 | $1,392 |
| AbbVie(2 entities) | 25 | $1,043 |
| Lilly USA, LLC | 11 | $691 |
| Revance Therapeutics, Inc. | 6 | $574 |
| Novo Nordisk | 6 | $527 |
| Sanofi | 6 | $419 |
| Johnson & Johnson(2 entities) | 4 | $330 |
| Teva Pharmaceuticals USA, Inc. | 7 | $300 |
| GSK | 7 | $259 |
| Actelion Pharmaceuticals US, Inc. | 3 | $184 |
| Boehringer Ingelheim | 4 | $170 |
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Incyte Corporation | 1 | $124 |
| United Therapeutics Corporation | 1 | $123 |
| Gilead | 2 | $96 |
| Amarin Pharma, Inc. | 2 | $83 |
| Merz North America, Inc. | 3 | $71 |
| Bayer | 3 | $69 |
| Novartis | 3 | $60 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $47 |
| B. Braun Medical Inc. | 1 | $33 |
| Amgen | 1 | $26 |
| Lundbeck LLC | 1 | $26 |
| LEO Pharma Inc. | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,962 in reported general payments places this provider in the 95th percentile of 466 family providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 17 | $579 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 16 | $402 |
| Levothyroxine Sodium | 18 | $161 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $93 |
| Furosemide | 12 | $86 |
Paid to pharmacies, not to this prescriber.
Other family in Pearl City
- Joey SesonHonolulu$48K
- Kanna DokgoHonolulu$26K
- John MosesHonolulu$24K
- Cecilia GreenWaipahu$21K
- Sherry Sutherland ChoyKahuku$21K
- Kristina HalloranAiea$12K
- Leif MarzHonolulu$11K
- Elizabeth CabreraWaianae$10K
- Ia Lynne AranaHonolulu$9K
- Noemi ArzagaHilo$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.